Zhang Y - Search Results

1

In vivo acquired sorafenib-resistant patient-derived tumor model displays alternative angiogenic pathways, multi-drug resistance and chromosome instability.

Hu G, Zhang Y, Ouyang K, Xie F, Fang H, Yang X, Liu K, Wang Z, Tang X, Liu J, Yang L, Jiang Z, Tao W, Zhou H, Zhang L. Hu G, et al. Among authors: zhang l, zhang y. Oncol Lett. 2018 Sep;16(3):3439-3446. doi: 10.3892/ol.2018.9078. Epub 2018 Jul 4. Oncol Lett. 2018. PMID: 30127946 Free PMC article.

2

[Effects of auto-tumor infiltrating lymphocytes induced by interleukin (IL)-12 with IL-2 on patients of primary hepatic carcinoma].

Zhang YX, Wang XY, Liu JB, Zhang SQ, Chen YR. Zhang YX, et al. Zhonghua Yi Xue Za Zhi. 2008 Apr 8;88(14):973-6. Zhonghua Yi Xue Za Zhi. 2008. PMID: 18756970 Clinical Trial. Chinese.

3

A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma.

Xu Y, Liu L, Liu J, Zhang Y, Zhu J, Chen J, Liu S, Liu Z, Shi H, Shen H, Hu Z. Xu Y, et al. Among authors: zhang y. Int J Cancer. 2011 Jan 15;128(2):412-7. doi: 10.1002/ijc.25342. Epub 2010 Mar 22. Int J Cancer. 2011. PMID: 20309940

4

IL12 polymorphisms, HBV infection and risk of hepatocellular carcinoma in a high-risk Chinese population.

Liu L, Xu Y, Liu Z, Chen J, Zhang Y, Zhu J, Liu J, Liu S, Ji G, Shi H, Shen H, Hu Z. Liu L, et al. Among authors: zhang y. Int J Cancer. 2011 Apr 1;128(7):1692-6. doi: 10.1002/ijc.25488. Epub 2010 Jun 2. Int J Cancer. 2011. PMID: 20521253

5

[Relationship between genetic polymorphism of promoter region let-7 and genetic susceptibility to hepatocellular carcinoma].

Huang F, Hu LM, Liu JB, Zhang YX, Hu ZB. Huang F, et al. Zhonghua Yu Fang Yi Xue Za Zhi. 2011 Dec;45(12):1093-8. Zhonghua Yu Fang Yi Xue Za Zhi. 2011. PMID: 22336344 Chinese.

6

Prognostic significance of FOXP1 as an oncogene in hepatocellular carcinoma.

Zhang Y, Zhang S, Wang X, Liu J, Yang L, He S, Chen L, Huang J. Zhang Y, et al. Among authors: zhang s. J Clin Pathol. 2012 Jun;65(6):528-33. doi: 10.1136/jclinpath-2011-200547. Epub 2012 Mar 15. J Clin Pathol. 2012. PMID: 22422806

7

Treatment of hepatic carcinoma by low-frequency ultrasound and microbubbles: A case report.

Shen ZY, Wu MF, Zhang YX, Shen K, Xia GL. Shen ZY, et al. Oncol Lett. 2015 Mar;9(3):1249-1253. doi: 10.3892/ol.2014.2812. Epub 2014 Dec 18. Oncol Lett. 2015. PMID: 25663892 Free PMC article.

8

Suppression of the nuclear transporter-KPNβ1 expression inhibits tumor proliferation in hepatocellular carcinoma.

Yang L, Hu B, Zhang Y, Qiang S, Cai J, Huang W, Gong C, Zhang T, Zhang S, Xu P, Wu X, Liu J. Yang L, et al. Among authors: zhang s, zhang t, zhang y. Med Oncol. 2015 Apr;32(4):128. doi: 10.1007/s12032-015-0559-1. Epub 2015 Mar 21. Med Oncol. 2015. PMID: 25794490

9

CTLA-4 gene polymorphism +49 A/G contributes to genetic susceptibility to two infection-related cancers-hepatocellular carcinoma and cervical cancer.

Hu L, Liu J, Chen X, Zhang Y, Liu L, Zhu J, Chen J, Shen H, Qiang F, Hu Z. Hu L, et al. Among authors: zhang y. Hum Immunol. 2010 Sep;71(9):888-91. doi: 10.1016/j.humimm.2010.05.023. Epub 2010 Jun 9. Hum Immunol. 2010. PMID: 20538028

10

[Relationship between genetic polymorphism in microRNAs precursor and genetic predisposition of hepatocellular carcinoma].

Zhang XW, Pan SD, Feng YL, Liu JB, Dong J, Zhang YX, Chen JG, Hu ZB, Shen HB. Zhang XW, et al. Zhonghua Yu Fang Yi Xue Za Zhi. 2011 Mar;45(3):239-43. Zhonghua Yu Fang Yi Xue Za Zhi. 2011. PMID: 21624236 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

262,609 results

Search Page

Filters